Novavax, Inc.
NVAX
$5.96
-$0.23-3.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 478.70M | -187.50M | -284.86M | -294.33M | -398.71M |
| Total Depreciation and Amortization | 44.69M | 48.50M | 46.77M | 45.39M | 44.33M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.79M | 3.26M | 99.67M | 119.34M | 144.40M |
| Change in Net Operating Assets | -725.38M | 48.48M | 47.53M | 143.88M | -261.96M |
| Cash from Operations | -189.21M | -87.26M | -90.88M | 14.28M | -471.93M |
| Capital Expenditure | -7.40M | -13.06M | -19.96M | -36.75M | -40.85M |
| Sale of Property, Plant, and Equipment | 192.64M | 192.64M | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -455.35M | -383.62M | -337.16M | -370.68M | -1.65M |
| Cash from Investing | -270.11M | -204.04M | -357.12M | -407.43M | -42.50M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.84M | -3.99M | -3.56M | -1.29M | -1.37M |
| Issuance of Common Stock | 258.38M | 265.24M | 367.95M | 562.90M | 366.72M |
| Repurchase of Common Stock | -666.00K | -666.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.24M | 0.00 | 0.00 | 0.00 | -616.00K |
| Cash from Financing | 247.64M | 260.58M | 364.39M | 561.61M | 364.73M |
| Foreign Exchange rate Adjustments | -5.78M | -7.80M | 5.83M | 9.15M | 8.69M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -217.46M | -38.52M | -77.78M | 177.62M | -141.01M |